logo
15:14 Dec 05

Laurus Labs Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1026.10
+12.60 (+1.24%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Laurus Labs Ltd. Financials

Laurus Labs Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1026.10
+12.60 (+1.24%)
15:14 Dec 05
Quality
image/svg+xml

66/100
High Financial Strength

Valuation
image/svg+xml

34/100
Mid Valuation

Technical

64/100
Technically Moderately Bullish

Strength

13

Weakness

4

Opportunity

1

Threats

0

8.01 %

ROE %

3.83 %

ROA %

12.67

EPS

82.99

BVPS

6.45 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
4935.57 6040.55 5040.83 5553.96 5928.62
Operating Expenses +
3513.14 4448.36 4263.33 4498.68 4662.41
Raw Material
2414.94 2752.28 2533.3 2533.91 2577.1
Increase Decrease in Cost
-221.17 22.04 -100.88 -55.93 1.38
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
501.53 580.64 639.93 719.52 760.34
Miscellaneous Expenses
1109.46 1404.82 1412.82 1511.9 1323.59
Operating Profit
1422.43 1592.19 777.5 1055.28 1266.21
Other Income
13.58 6 26.34 59.93 83.02
Depreciation
251.49 324.08 384.58 430.09 440.87
Interest
100.67 165.17 182.9 200.83 218.31
Profit before tax and exceptio..
1083.85 1108.94 236.36 484.29 690.05
Exceptional Items
0 0 0 0 0
PBT
1083.85 1108.94 236.36 484.29 690.05
Provision for Taxation
251.42 312.3 68.15 129.88 186.77
Net Profit
832.43 796.64 168.21 354.41 503.28
NET Profit after MI
827.52 790.11 160.55 358.32 508.83
EPS
15.42 14.64 2.97 6.64 9.44
Operating Profit Margin (%)
28.82 26.36 15.42 19 21.36
Net Profit Margin (%)
16.77 13.08 3.19 6.45 8.58

Laurus Labs Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 27.60 27.60 27.60 27.60 27.20 27.20
FII 26.20 25.70 25.50 25.60 26.10 25.70
Public 11.70 11.90 11.80 12.70 13.00 13.50
Others 34.50 34.80 35.10 34.10 33.70 33.60
Shareholder Shares Holding %
Research 360 logo
Download Our App On: